Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PQN and DQN: algorithms for expression microarrays.

Wei-min Liu1, Rui Li, James Z Sun

  • 1Roche Molecular Systems, Inc., 4300 Hacienda Drive, Pleasanton, CA 94588, USA. wei-min.liu@roche.com

Journal of Theoretical Biology
|August 8, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Performance characteristics of a polymerase chain reaction-based assay for the detection of EGFR mutations in plasma cell-free DNA from patients with non-small cell lung cancer using cell-free DNA collection tubes.

PloS one·2024
Same author

Pan-Tumor Analytical Validation and Osimertinib Clinical Validation in EGFR Mutant Non-Small-Cell Lung Cancer, Supporting the First Next-Generation Sequencing Liquid Biopsy in Vitro Diagnostic.

The Journal of molecular diagnostics : JMD·2023
Same author

Tumor Genomic Testing for >4,000 Men with Metastatic Castration-resistant Prostate Cancer in the Phase III Trial PROfound (Olaparib).

Clinical cancer research : an official journal of the American Association for Cancer Research·2022
Same author

A novel automated SARS-CoV-2 saliva PCR test protects a global asymptomatic workforce.

Scientific reports·2021
Same author

Olaparib for Metastatic Castration-Resistant Prostate Cancer.

The New England journal of medicine·2020
Same author

Programmed Cell Death Ligand 1 Expression in Untreated EGFR Mutated Advanced NSCLC and Response to Osimertinib Versus Comparator in FLAURA.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2019

We developed two novel gene expression algorithms, PQN and DQN, designed for robust analysis across different assays and microarrays. These methods improve accuracy by using quantile normalization for reliable differential expression detection.

Area of Science:

  • Bioinformatics
  • Computational Biology
  • Gene Expression Analysis

Background:

  • Accurate gene expression analysis is crucial for biological research.
  • Existing algorithms often struggle with robustness across varying assay types and experimental conditions.
  • Minimizing false positive errors while detecting true expression differences is a key challenge.

Purpose of the Study:

  • To propose and evaluate novel algorithms for robust gene expression analysis.
  • To address the challenge of assay variability in microarray studies.
  • To improve the reliability of differential expression detection.

Main Methods:

  • Development of two algorithms: PQN (Perfect Quantile Normalization) and DQN (Difference Quantile Normalization).
  • Both algorithms utilize non-central trimmed means and quantile normalization.

Related Experiment Videos

  • Comparison against established methods (RMA, GCRMA, DCHIP, PLIER, MAS5) using Affymetrix Latin square and custom bone marrow datasets.

    • Main Results:

    • PQN and DQN demonstrate robustness to changes in array types and assay protocols.
    • Normalization to common quantiles at the probe set level is essential for cross-study comparability.
    • Identified potential for computational improvement in Area Under the Curve (AUC) of Receiver Operating Characteristic (ROC) calculations.

    Conclusions:

    • The proposed PQN and DQN algorithms offer improved accuracy and robustness for gene expression analysis.
    • These methods are particularly valuable in studies involving multiple microarray types or assay variations.
    • Further optimization of performance metrics like AUC computation is recommended.